Filter
389
Text search:
genome
Featured
Recommendations
49
New Publications
75
Language
Document type
No document type
163
Studies & Reports
82
Guidelines
76
Manuals
25
Strategic & Response Plan
14
Fact sheets
13
Training Material
9
Situation Updates
4
Infographics
2
Resource Platforms
1
Countries / Regions
India
20
Global
16
Western and Central Europe
10
Latin America and the Carribbean
9
Russia
9
Germany
8
South Africa
7
Tanzania
6
Nigeria
5
Uganda
5
Brazil
5
Ukraine
5
Africa
5
Eastern Europe
5
Middle East and North Africa
4
Senegal
3
Ethiopia
3
Chad
3
West and Central Africa
3
South–East Asia Region
3
Liberia
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Niger
2
Haiti
2
South Sudan
2
Kenya
2
Peru
2
Colombia
2
Bolivia
2
Angola
2
East and Southern Africa
2
Western Pacific Region
2
Venezuela
2
France
2
Spain
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Philippines
1
Somalia
1
Nepal
1
Pakistan
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Syria
1
Cambodia
1
China
1
Rwanda
1
Indonesia
1
Mauritania
1
Bangladesh
1
Malawi
1
Mozambique
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
Eastern Europe and Central Asia
1
Asia
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Denmark
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
83
Clinical Guidelines
62
Public Health
21
Pharmacy & Technologies
16
Key Resources
12
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
66
TB
47
Rapid Response
42
NTDs
38
AMR
29
Mental Health
23
Zika
14
Planetary Health
12
HIV
11
Ebola
10
Refugee
8
NCDs
8
Polio
6
Conflict
4
Global Health Education
4
Caregiver
4
Disability
3
Specific Hazards
3
Cholera
2
Pharmacy
2
Health Financing Toolbox
2
South Sudan
1
Natural Hazards
1
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o
...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
New edition
Rreport of a WHO Consultative Meeting Kolkata India 2012
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
PLoS ONE 7(12): e52986. doi:10.1371/journal.pone.0052986. Opern Access please download from the website
The goals of Ebola virus disease (EVD) surveillance during Phase 3 of the Ebola response are to promptly detect new, suspected EVD cases and deaths so as to trigger appropriate response, including rapid diagnosis, case isolation and management, contact tracing, safe burials, and the identification o
...
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent
...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral
...
Policy framework.
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
Protocol and preliminary evaluationas of Jan 17, 2020
